Ouwens, Mario J. N. M.
Mukhopadhyay, Pralay
Zhang, Yiduo
Huang, Min
Latimer, Nicholas
Briggs, Andrew
Funding for this research was provided by:
AstraZeneca
Article History
First Online: 18 May 2019
Compliance with Ethical Standards
:
: The ATLANTIC study (NCT02087423) was funded by AstraZeneca.
: Mario J.N.M. Ouwens and Pralay Mukhopadhyay are employees of AstraZeneca. Yiduo Zhang is an employee of AstraZeneca and owns stock in AstraZeneca. Min Huang is a former employee of AstraZeneca. Nicholas Latimer has received consultancy fees from AstraZeneca in relation to material presented in this manuscript, and has also received consultancy fees from Bristol-Myers Squibb and Pfizer for providing modelling advice. Andrew Briggs has received consultancy fees from AstraZeneca in relation to material presented in this manuscript, and has also received consultancy fees from Bristol-Myers Squibb and Merck (who are manufacturers of immuno-oncologic therapies).